• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Axonics Inc (NQ: AXNX )

    67.51 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Jun 18, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 67.51
    Bid (Size) 27.01 (2)
    Ask (Size) 68.95 (1)
    Prev. Close 67.51
    Today's Range 67.51 - 67.51
    52wk Range 47.94 - 69.68
    Shares Outstanding 46,134,513
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Axonics Receives Regulatory Approval for Recharge-Free SNM System in Australia
    From Axonics, Inc.
    Via Business Wire
    AXNX Stock Earnings: Axonics Misses EPS, Beats Revenue for Q1 2024
    AXNX stock results show that Axonics missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
    Via InvestorPlace

    Performance

    YTD
    +13.06%
    +13.06%
    1 Month
    -0.04%
    -0.04%
    3 Month
    -1.80%
    -1.80%
    6 Month
    +15.03%
    +15.03%
    1 Year
    +29.75%
    +29.75%

    More News

    Read More
    Axonics Reports First Quarter 2024 Financial Results
    From Axonics, Inc.
    Via Business Wire
    Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
    Via MarketBeat
    Beyond The Numbers: 7 Analysts Discuss Axonics Stock
    Via Benzinga
    Analyst Scoreboard: 5 Ratings For Axonics
    Via Benzinga
    Why Axonics Stock Soared Today
    Via The Motley Fool
    FDA Classifies Boston Scientific's Recall For Device To Stop Blood Flow As 'Most Serious'
    Via Benzinga
    Exposures Product Safety
    Axonics Stockholders Approve Merger Agreement with Boston Scientific
    From Axonics, Inc.
    Via Business Wire
    Axonics Receives CE Mark Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System
    From Axonics, Inc.
    Via Business Wire
    Axonics Responds to ITC Action by Medtronic
    From Axonics, Inc.
    Via Business Wire
    Health Care Company Boston Scientific Announces Acquisition of Axonics
    Via Benzinga
    Axonics Reports Fourth Quarter and Fiscal Year 2023 Financial Results
    From Axonics, Inc.
    Via Business Wire
    AXONICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Axonics, Inc. - AXNX
    From Kahn Swick & Foti, LLC
    Via Business Wire
    Why Medical Devices Giant Boston Scientific Shares Are Rising Today
    Via Benzinga
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    Stock Market Rally Rebounds; Nvidia, Tesla, JPMorgan, Bitcoin ETFs In Focus: Weekly Review
    Via Investor's Business Daily
    Topics ETFs
    Robinhood, Palo Alto Networks And 2 Other Stocks Insiders Are Selling
    Via Benzinga
    10 Top Stocks With a Strong Buy Rating Right Now
    Via InvestorPlace
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    Why Is Crocs (CROX) Stock Up 20% Today?
    Via InvestorPlace
    Why Is Axonics (AXNX) Stock Up 20% Today?
    Via InvestorPlace
    Why Is Bladder Disorder Focused Axonics Stock Trading Higher Today?
    Via Benzinga
    Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    J&J, Merck, Boston Scientific Debut Trio Of Splashy Takeovers Topping $3 Billion In Value
    Via Investor's Business Daily
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.